# Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial

> **NCT03576599** · PHASE4 · TERMINATED · sponsor: **Oslo University Hospital** · enrollment: 5 (actual)

## Conditions studied

- Stress Fracture Foot
- Stress Fracture Ankle

## Interventions

- **DRUG:** Zoledronic Acid Injectable Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03576599
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-29
- **Primary completion:** 2019-06-26
- **Final completion:** 2019-06-26
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** difficult to include patients
- **Last updated:** 2019-09-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03576599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03576599, "Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03576599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*